跳至主要内容
临床试验/KCT0006124
KCT0006124招募中未知

Efficacy and safety of 1L PEG+Asc vs 2L PEG+Asc in the hematochezia patients: a prospective multicenter study

Yonsei University, Wonju Severance Christian Hospital0 个研究点目标入组 196 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20?(Year) 至 84?(Year)(—)
性别
All

入选标准

  • Subjects who have agreed to participate in the study with hematochezia between 20 years of age and under 85 years of age and who are scheduled to undergo diagnostic colonoscopy

排除标准

  • 1. People who have had a colon resection
  • 2. Patients with congestive heart failure, acute myocardial infarction within 6 months
  • 3. American Society of Anesthesiology class III or higher
  • 4. People who have a history of cirrhosis, ascites, chronic kidney disease, inflammatory bowel disease, serious inflammatory disease, etc.
  • 5. Handicapped (cognitive disorder, intellectual disability), pregnant women
  • 6. Patients with ileus, intestinal obstruction, and toxic giant colon
  • 7. Patients who refuse to sign the subject consent form

研究者

发起方
Yonsei University, Wonju Severance Christian Hospital

相似试验